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Abstract 
U.S. healthcare consumers have access to various provider ratings from several 
organizations that are meant to assist in selecting their healthcare providers.  Leapfrog 
Hospital Safety Grades is one such rating system that professes to allow consumers the 
ability to select the best hospital for their care. However, since consumers ranking 
mortality risk as their most important concern, it is essential to determine if Leapfrog 
grades align with consumer expectations. Andersen’s Phase-4 behavioral model of 
healthcare utilization was used as the foundation for understanding healthcare consumer 
preferences. This study was designed to determine if Leapfrog grades are predictive of 
CMS 30-day mortality rates for pneumonia, chronic heart failure, and acute myocardial 
infarction data, while also adjusting for selected organizational descriptors: state of 
residency, Medicare expansion, safety-net status, ownership type, teaching classification, 
and number of licensed beds.  Linear regression demonstrated that Leapfrog grades are 
not reliable predictors of the 3 inpatient mortality rates analyzed. The study demonstrated 
that ownership type was a significant predictor for 2 of the 3 dependent variables.  
Furthermore, most of the covariates also provided some predictive value for at least 1 of 
the included outcomes; however, in most cases, the effect (β) was small.  This study can 
help provide positive social change by elucidating that Leapfrog grades are not reliable 
predictors of patient outcomes for consumers, while also demonstrating that efforts to 
reduce 30-day mortality rates, especially for pneumonia, can be targeted by selected 
states, ownership type, and teaching status. 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
 Consumer available provider comparative quality information has been increasing 
in availability since the passage of the Affordable Care Act (Scanlon, Shi, Bhandari, & 
Christianson, 2015).  Such quality comparative data is currently available from many 
sources, ranging from private to public entities that may or may not charge for 
participating. My goal with this study was to determine if the publicly available hospital 
Leapfrog Hospital Safety Grades (Leapfrog grades) provide consumers with information 
that is predictive of Centers for Medicare and Medicaid Services (CMS) 30-day mortality 
rates for three diagnoses (pneumonia, congestive heart failure [CHF], and acute 
myocardial infarctions [AMI]).   
Problem Statement 
U.S. healthcare is so complex that the seemingly simple act of comparing health 
outcome data, hospital safety information, and organization descriptors among healthcare 
enterprises has proven difficult.  Several rating organizations, using their proprietary 
rating systems, have attempted to compare hospitals.  The problem with these rating 
systems is that they measure different operational aspects and do not correlate with each 
other (Rothberg, Morsi, Benjamin, Pekow, & Lindenauer, 2008).  The lack of correlation 
only adds to the confusion that healthcare consumers are already experiencing when 
selecting a hospital in which to receive their care. Austin et al. (2015) demonstrated how 
not a single hospital is designated as a high performer among all four rating systems (The 
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Leapfrog Group, U.S News, Hospital Compare, and Consumer Reports) they analyzed.  
The authors stated that only 10% of the hospitals that appeared in any single rating 
system as a high performer was rated as a high performer by any other rater (Austin et al., 
2015).  With so much disparity among the various survey findings, one begins to question 
if the rating systems are valid as a resource to consumers for selecting their healthcare 
providers. 
Consumer-oriented scores/grades from each rating organization’s unique 
evidence-based quality indicator framework are meant to guide healthcare consumers in 
selecting their healthcare providers based on a proprietary score/grade of excellence 
(Austin et al., 2015).  Hence, this research addressed the gap that exists in determining if 
the Leapfrog consumer rating system is a good predictor of patient outcomes.   
Purpose of the Study 
The primary purpose of this study was to determine if Leapfrog hospital grades 
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS 
datasets from all hospitals that have sufficient data elements from eight states (GA, MD, 
OH, NC, PA, TN, VA, and WV), similar to other Leapfrog-focused studies (Pakyz, 
Wang, Ozcan, Edmond, & Vogus, 2017).  While other studies have looked at the 
relationship between an organization’s financial performance and CHF, AMI, and 
pneumonia mortality rates (Nguyen, Halm, & Makam, 2016), this study was unique in 
that it looked at the information available to consumers on which they base their 
healthcare purchasing decisions. Secondarily, a comparison of the linear regressions 
derived from each organization’s grade was used to determine if the hospital grade was 
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predictive of the 30-day mortality data. Since the most significant measure of a healthcare 
organization’s quality is patient outcomes (e.g., mortality rates), by performing a 
retrospective analysis one can compare if the rating organization’s provided healthcare 
grades are correlated with hospitals that have better patient outcomes. Additional 
stratifications using covariates of hospital-level quality data and descriptors (e.g., 
ownership type) were used to look for relationships, using regression analysis, and biases 
that existed between the grades and other independent variables. 
Research Questions and Hypotheses 
RQ1: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with the CMS pneumonia mortality rate data adjusting for each 
covariate: licensed beds, ownership type, state of residency, safety net hospital status, 
state Medicaid expansion status, and organization’s teaching status? 
H11: The available consumer available health organization’s Leapfrog grade is 
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed 
beds, ownership type, state of residency, safety net hospital status, state Medicaid 
expansion status, and organization’s teaching status. 
H01: There is no correlation between Leapfrog grades and patient health mortality 
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership 
type, state of residency, safety net hospital status, state Medicaid expansion status, and 
organization’s teaching status. 
RQ2: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS congestive heart failure (CHF) patient mortality rate 
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data adjusting for each covariate: licensed beds, ownership type, state of residency, safety 
net hospital status, state Medicaid expansion status,  and organization’s teaching status? 
H12: The available consumer available health organization’s Leapfrog grade is 
predictive of patient chronic heart failure (CHF) mortality rate data adjusting for each 
covariate: licensed beds, ownership type, state of residency, safety net hospital status, 
state Medicaid expansion status, and organization’s teaching status. 
H02: There is no correlation between Leapfrog grades and patient mortality rates 
based on CHF data adjusting for each covariate: licensed beds, ownership type, state of 
residency, safety net hospital status, state Medicaid expansion status, and organization’s 
teaching status. 
 RQ3: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality 
rate data adjusting for each covariate: licensed beds, ownership type, state of residency, 
safety net hospital status, state Medicaid expansion status,  and organization’s teaching 
status? 
H13: The available consumer available health organization’s Leapfrog grade is 
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed 
beds, ownership type, state of residency, safety net hospital status, state Medicaid 
expansion status, and organization’s teaching status. 
H03: There is no correlation between Leapfrog grades and patient health mortality 
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership 
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type, state of residency, safety net hospital status, state Medicaid expansion status, and 
organization’s teaching status. 
Theoretical Foundation of the Study 
I used Andersen’s behavioral model of healthcare utilization (Andersen, 1995).  
This approach was appropriate for ascertaining if the quantitative data were predictive for 
determining if an association existed between the independent variables (grades and 
descriptive characteristics) and the dependent variables (30-day mortality rates).  
Specifically, the three dependent variables used for this study consisted of pneumonia, 
CHF, and AMI 30-day mortality rates derived from publicly available CMS data.  
Andersen described in his Phase-4 model that consumers’ preference and satisfaction 
play an essential part in the selection of healthcare services (Andersen, 1995).  This 
comparison included both the independent and dependent variables that are publicly 
available to healthcare consumers and are meant to influence patient preference and 
provider selection.   
Nature of the Study 
The study was a quantitative study using a secondary dataset obtained from the 
Centers for Medicare and Medicaid Services (CMS), The Leapfrog Group, and the 
American Hospital Association (AHA). The study was conducted to determine if the 
Leapfrog’s publicly available organization health grades are reliable predictors of 30-day 
mortality rates (pneumonia, CHF, AMI) that are derived from the CMS database.  Further 
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analysis was performed assessing whether the outcome data demonstrated bias by also 
correlating with the descriptor elements (covariates) with the same health outcome data.   
The study was built upon similar studies that also looked to correlate the 
predictability of publicly available health scores/grades and quality indicators. One 
similar study looked to determine a relationship between Leapfrog scores and hospital-
acquired infections (Pakyz et al., 2017) and provides an approach that was used for this 
research study.   
Literature Search Strategies 
 The Walden University and the Virginia Commonwealth University (VCU) 
online libraries and Google Scholar were searched using various keywords and phrases 
(e.g., consumer healthcare data, Leapfrog, HQA, patient mortality rates, Anderson’s 
behavioral model, and Hospital Compare).  The various searches were refined to 
primarily display articles that were published within the immediate past 5 years (2014 – 
2018).  Articles primarily from ProQuest Central, MEDLINE, PubMed, SAGE Journals, 
CINAHL Plus, and from peer-reviewed sources were used. 
 Additional sources of relevant articles were found within the various journal 
articles being reviewed.  This process led to chaining of related papers that was initiated 
by the original keyword search approach but allowed for the finding specific articles of 
interest in either the Walden University or Virginia Commonwealth University databases. 
This approach was found to be an excellent source of additional articles; however, this 
approach often led to articles that were outside of the 5-year primary search period. 
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 The main subjects of the literature searches pertained to the main sections and 
themes of this paper.  The significance of each article used in this paper is described 
within the areas they are referenced.   
Literature Review 
Introduction 
The U.S. healthcare system has been on a journey towards improving the quality 
of patient care based on current best practices, expanding access, and decreasing costs.  
The healthcare industry has relied upon the use of quality benchmarking for measuring 
improvements to differentiate organizational quality.  However, to date, the improvement 
of healthcare quality initiatives has produced limited improvement using current quality 
indicators (Burstin, Leatherman, & Goldmann, 2016).  As quality benchmarking 
continues to help determine organizational reimbursement through quality reimbursement 
modeling, it has been demonstrated that this approach may lead to organizations 
becoming less likely to improve the organization’s quality of care measures due to the 
loss of revenue (Manary, Staelin, Boulding, & Glickman, 2015).  Quality improvement is 
becoming more critical as healthcare reimbursement is partially determined using quality 
measures, including patient survey data. 
The fact that quality outcome data surveys are now part of the reimbursement 
level calculations, some hospitals may be negatively impacted by the nature of the data 
collected and presented to the public as hospital quality indicators.  Figueroa, Wang, and 
Jha (2016) demonstrated that reimbursement penalties adversely impact the problems 
associated with comparing hospitals using the pay-for-performance (P4P) models. These 
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issues associated with these reimbursement models have also demonstrated that large, 
major teaching, and safety-net hospitals are notably more negatively impacted more than 
other hospital types (Figueroa et al., 2016; Manary et al., 2015).  This data would imply 
that major academic medical centers, which tend to be large major teaching safety-net 
hospitals, would be the most impacted of all hospital types. However, large, major 
teaching, and safety-net hospitals are not the only organizational characteristics that are 
predictive of profitability, and as discussed above, impact quality indicators.   
Patient acuity, based on case mix index, demonstrates a statistical difference 
among organizations with diverse ownership types, university affiliations, teaching 
status, and as expected, trauma center level designations (Mendez, Harrington, 
Christenson, & Spellberg, 2014).  Furthermore, using both private and government payer 
data, some patterns begin to emerge that can predict profitability among system types and 
locations (Bai & Anderson, 2016) that could be based on acuity differences.   
The use of the 30-day mortality rate has been used to provide consumers with a 
quality indicator needed to help determine hospital quality (Shahian, Wolf, Iezzoni, Kirle, 
& Normand, 2010).  Hu et al., (2017) determined that Hospital Compare’s overall scores, 
which are derived from the various quality indicators, did not demonstrate a correlation 
that would allow for consumers to make informed healthcare decisions.  However, the 
authors did not specifically attempt to correlate 30-day mortality rates for pneumonia, 
CHF, and AMI with the Hospital Compare scores, or any of the other available 
scores/grades (e.g., Leapfrog), and instead analyzed at all the quality indicators to 
determine consistency among the scores and all quality indicators used in calculating 
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each organization’s score (Hu et al., 2017). Therefore, with the advent of multiple 
publicly available scores/grades, the question then becomes which, if any, of the quality 
indicators, correlate with the scores/grades that assigned to each hospital.  
Leapfrog Group Organization Grades 
Organizational Overview 
 The Leapfrog Group produces letter safety grades for acute care hospitals (A, B, 
C, D, or F) to provide consumers with information to select safe hospitals from which to 
receive their care.  Leapfrog describes themselves as 
The Leapfrog Group is a nonprofit watchdog organization that 
serves as a voice for health care purchasers, using their collective 
influence to foster positive change in U.S. health care. Leapfrog is 
the nation’s premier advocate of hospital transparency—collecting, 
analyzing and disseminating hospital data to inform value-based 
purchasing. (The Leapfrog Group, n.d.) 
The Leapfrog grades are made available to the public on the organization’s 
website.  Consumers can search for various hospitals and compare safety grades to guide 
provider selection.    
Scoring Methodology 
For the Fall 2018 grades, Leapfrog’s grade for each organization is determined 
through the weighting of 28 national performance measures derived from CMS data, 
Leapfrog’s organization survey, and other secondary data sources such as the American 
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Hospital Association’s Annual Survey and IT Supplement (The Leapfrog Group, 2018, 
p.4). The grade is calculated by converting the various performance measures into a z-
score and then, using Leapfrog’s proprietary weighting, used to produce value, that if 
higher than the mean, is considered better performance, and lower than the mean, is 
considered worse. (Austin et al., 2014). 
Usefulness of Consumer Available Health Scores/Grades 
 As healthcare moves towards a consumer-driven marketplace, hospital 
reimbursement levels will be impacted by consumers.  The Hospital Value-Based 
Purchasing Program implemented by CMS calculates hospital reimbursement levels on 
patient outcomes, consumer satisfaction, quality indicators, and efficiency scores 
(Manary et al., & Glickman, 2015). Currently, CMS satisfaction scores account for 1.5% 
of hospital reimbursement (Tefera, Lehrman, & Conway, 2016).  It can be expected that 
reimbursement will continue to be increasingly dependent on hospital performance and 
patient satisfaction. 
 The various formulations by Leapfrog, Hospital Compare, and Consumer Reports, 
and others consider, through a proprietary combination of hospital performance, safety, 
and patient satisfaction, to produce a score/grade that helps consumers determine where 
to receive their care (Austin et al., 2015).  Therefore, the availability of consumer 
scores/grades has the potential to influence which hospitals consumers select to receive 
their care (Sandmeyer, & Fraser, 2016).  However, the authors stipulated that consumers 
as a whole have yet to begin to use these available scores/grades to make their healthcare 
decisions (Sandmeyer, & Fraser, 2016). Regardless, it is important to determine if the 
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scores/grades are providing consumers with information that correlates with performance 
(e.g., 30-day mortality rates) and not merely stylistic (e.g., hotel-like lobbies) approaches 
that pander to consumerism.   
For example, The Malcolm Baldrige National Quality Award uses quality, 
leadership, business, and satisfaction data indicators to select the award winners (Evans 
& Mai, 2014).  While the Baldrige Award is a coveted and respected award, hospitals that 
win the award have not demonstrated a difference from other organizations when 
comparing CMS patient outcomes or satisfaction scores (Schulingkamp & Latham, 
2015). 
Hospitals are in the business to treat and care for the sick and injured.  
Organizations continue to pursue higher patient satisfaction scores to improve both their 
patient care, reimbursement levels, and to have higher ratings than their competitors for 
marketing purposes (Smith, Reichert, Ameling, & Meddings, 2017). The question must 
be asked if Leapfrog grades reliably predict 30-day mortality rates for pneumonia, AMI, 
and CHF.  With the new emphasis on aesthetics and concierge services, it cannot be 
forgotten that patients’ outcomes are at the core of hospitals existence; and reduced 
mortality rates remain patients’ primary concern (Mühlbacher & Bethge, 2015). 
30-day Mortality Rates (Dependent Variables) 
 The usefulness of using the CMS derived data must be demonstrated to perform 
an analysis using available Leapfrog grades for predicting hospital-level patient 30-day 
mortality rates.  First, it had to be determined if dependent variables are useful in 
demonstrating correlations among hospitals.  Dy et al. (2016) were able to demonstrate 
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that 30-day mortality rates for CHF among 895 U.S. hospitals were correlated with 
patient satisfaction scores (HCAHPS) and readmission rates.  However, the authors found 
that heart failure mitigation quality process indicators (e.g., ACE inhibitors) did not 
demonstrate any statistical correlation (Dy et al., 2016).  The same correlations between 
readmission rates and all three 30-day mortality rates have also been demonstrated (Hu et 
al., 2017).  Other studies using CHF, AMI, and pneumonia 30-day mortality data and 
were able to demonstrate that the only CHF mortality rates, and not AMI and pneumonia 
rates, were correlated with quality measure data (Ryan, Nallamothu, & Dimick, 2012).  
Therefore, the usefulness of the three selected dependent variables, and the fact they are 
independent of each other, has been demonstrated. 
 The rates for the 30-day mortality rates are recorded as a percentage of deaths < 
30 days from the date of admission.  The CMS 30-day mortality rates are risk adjusted 
for age, medical history, and comorbidities (CMS.gov, 2016). 
Independent Variables 
Leapfrog 
 Leapfrog Group developed a hospital safety grade (A, B, C, D, or F) based on 
both survey results and other publicly available data.  The hospital score is made 
available to the public on the organization’s website to provide consumers with the 
ability to compare hospitals across the United States. The unique aspect of the Leapfrog 
grade is the focus on patient safety and not direct patient outcomes (e.g., 30-day mortality 
rates) or satisfaction survey data (e.g., HCAHPS).  Again, making the argument that 
patient outcomes (i.e., the prevention of patient death) are the ultimate goal for hospitals, 
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then one must ask if the Leapfrog grades, based on patient safety indicators, correlate 
with outcome data. 
 Austin et al. (2014), did determine that Leapfrog grades demonstrate statistically 
significant negative bias based on region, number of beds, and ownership type.  
However, one of the significant issues with the Leapfrog grade is that participants who 
complete the proprietary survey get to use their data.  For organizations that do not wish 
to pay and complete the Leapfrog survey, the Leapfrog Group uses a combination of 
publicly available safety data and a process of exclusion and recalibration of the data 
(Austin et al., 2014).   This self-reporting of results allows for organizations to produce 
values based on their own criteria and not necessarily the same as the CMS reporting 
methodology.  This inconstancy has demonstrated that self-reporting produced better 
values than those reported to CMS (Smith et al., 2017).  Furthermore, this could 
potentially cause those hospitals that self-report to have more favorable grades than those 
hospitals that do not self-report.  Smith et al. (2017) did demonstrate that self-reporting of 
results did produce improved scores over those organizations that did not self-report and 
whose CMS data was used.  Additionally, the authors also found that the self-reported 
values had little association with the mandatorily reported CMS data (Smith et al., 2017).  
Covariates and 30-day Mortality Rates 
Safety-net status. Safety-net hospitals do not have a single definition.  For this 
study, the definition used by Gilman et al., (2015) will be used.  Gilman et al. defined 
safety-net hospitals as those organizations that are in the top quartile for receiving the 
highest percentage of disproportionate-share hospital (DSH) payments for providing 
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uncompensated care. In this study, I analyzed each state separately, and the top quartile 
of hospitals in each state was designated as safety-net facilities to divide the hospitals for 
this covariate analysis.  
The purpose of including safety-net status as a covariate is due to differences in 
hospital profitability.  Hospitals that provide increased amounts of uninsured patient care 
are less profitable (Bai & Anderson, 2016).  It is easy to understand that if an 
organization is less profitable, there could potentially be decreased investments in capital 
and infrastructure that might directly or indirectly impact patient outcome data.  Contrary 
to what might be expected, safety-net hospitals, organizations that have increased 
Medicaid patients and an increasingly disproportionate amount of uncompensated care 
(Gilman et al., 2014), have been shown to have no statistical difference between patient 
outcomes when compared to nonsafety-net hospitals (Gilman et al., 2015).  Therefore, it 
would be expected that an organization’s safety-net designation should not influence the 
designated Leapfrog grade.  While the various analyses performed used direct 
correlations between safety-net designation and 30-day mortality rates, I used safety-net 
status as a covariate to see if the scores/grades demonstrate any statistically significant 
correlations. 
Ownership type.  Ownership type has been used to differentiate hospital 
performance to determine if the philosophical and mission differences make a difference 
in patient outcomes (Zhao, Haley, Spaulding, & Balogh, 2015).  Ownership type for this 
study was divided into three groups: for-profit, not-for-profit, and public.  When AMI, 
CHF, and pneumonia hospital readmissions were previously analyzed using hospital 
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ownership as a variable, it was determined to have limited effect on the variability 
demonstrated among hospitals (Herrin et al., 2015).  However, the authors looked at 
readmission rates and not mortality rates for the same three outcomes.  Furthermore, 
Herrin et al., (2015) also used geographic location as the primary variable which 
accounted for 58% of hospital variability for the above readmission rates.  Therefore, the 
slight increase in hospital variability that may have been attributable to hospital 
ownership could still be significant, just less than location.  
 When other studies, at least in Chile, there were differences demonstrated among 
hospitals with different ownership types for total mortality rates (Cid Pedraza, Herrera, 
Prieto Toledo, & Oyarzún, 2015).  While the Chilean authors looked at total mortality 
rates, this study will include a more focused 30-day mortality rate for only three patient 
outcomes (i.e., CHF, AMI, and pneumonia) using CMS data for the included eight states. 
Teaching status. An organization’s teaching status has been shown to 
demonstrate outcome differences regarding patient outcomes.  Burke, Frakt, Khullar, 
Orav, and Jha (2017) were able to demonstrate that teaching hospitals did demonstrate 
statistically lower mortality rates for CHF, AMI, and pneumonia outcomes when 
compared to nonteaching hospitals.  Furthermore, the authors were also able to 
demonstrate a gradient for these three outcomes among hospitals that were defined as 
major teaching, minor teaching, and nonteaching (Burke et al., 2017).  The gradient 
demonstrated increased mortality rates as the status went from major to minor to 
nonteaching hospitals (Burke et al., 2017).  However, other studies demonstrated no 
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differences for other mortality rates (open versus endovascular aortic aneurysm repairs) 
between teaching and nonteaching hospitals (Hicks et al., 2016). 
 This study used the teaching status, using the AHA annual survey hospital 
responses to identify hospitals teaching status.  While this study compared teaching status 
and the 30-day outcomes for CHF, AMI, and pneumonia, the status served as a covariate 
helping to demonstrate if the indirect variables demonstrate variability among hospitals 
of the various teaching statuses.  
 AHA survey data delineated among the three teaching statuses: major being 
members of both the Accreditation Council for Graduate Medical Education (ACGME) 
and Association of American Medical Colleges (AAMC) Council of Teaching Hospitals 
(COTH); minor is defined as those accredited by ACGME, but are not COTH members; 
nonteaching are all hospitals without either ACGME or COTH membership (Rivard, 
Christiansen, Zhao, Elixhauser, & Rosen, 2008).  
Licensed beds (size).  Hospital size is customarily defined by the number of 
licensed beds that the facility has available to provide patient care.  The correlation is 
often believed that larger size facilities offer more diverse and sophisticated care.  The 
use of hospital size as a covariate is not meant to determine why any difference that may 
be demonstrated for 30-day mortality rates among facilities.  Nor is the study meant to 
speculate and why these differences, if any, exist; but rather to demonstrate if hospital 
size is correlated, positively or negatively, when compared to the hospital Leapfrog 
grades. While bed size is not to indicate a direct causal factor and purely a predictor 
variable, differences among hospitals based on size have been demonstrated.  Sheetz, 
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Dimick, and Ghaferi (2016) were able to demonstrate that hospital size was a predictor of 
patient outcomes (e.g., failure to rescue) with smaller hospitals (< 200 beds) performing 
statistically worse than larger hospitals (> 200 beds).  For this study, beds were separated 
into four groups (< 100 beds, 100 – 199 beds, 200 – 499 beds, and >500 beds) to 
determine if differences were demonstrated among the various hospital size groupings. 
State of residency.  Because of differences in state health policies, the study will 
also look to determine if the state in which the hospital is located provides any 
statistically significant bias regarding Leapfrog grades. To help mitigate geographic 
differences among patients from each state, the states used for this study are also 
relatively clustered together with each state sharing a border with at least two other states, 
and with six of the eight sharing a border with at least three study states (Figure 1).   
 Health disparities among various states and U.S. geographic regions have been 
noted, including mortality rates.  Roth et al., (2017) was able to describe significant 
differences among various U.S. geographical regions when comparing mortality rates for 
heart disease and stroke.  Because some of these differences have been attributed to 
socioeconomic differences (Singh, Siahpush, Azuine, & Williams, 2015), it only adds to 
the necessity to reduce geographic variability by keeping the study states in the same 
general region (see Figure 1). 
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Figure 1: States used for the study 
 
Medicaid expanded versus nonexpanded states.  There have been mixed results 
from studies regarding health disparities between states that expanded Medicaid and 
those that did not expand Medicaid under the Affordable Care Act (ACA; Bhatt & Beck-
Sagué, 2018; Anderson et al., 2016).  In states that expanded Medicaid, infant mortality 
was found to be lower (Bhatt & Beck-Sagué, 2018).  However, other studies have not 
shown any difference when comparing states that did and did not expand Medicaid for in 
length of stay and other mortality rates (Anderson et al., 2016).  
 The inclusion of Medicaid expansion is not meant to determine if there is a direct 
causal effect with Leapfrog grades, but rather to see if hospitals in states with Medicaid 
expansion are statistically significantly different from those that did not expand 
Medicaid.  Table 1 lists the states included (four that expanded and four did not expand 
Medicaid) and their Medicaid status as of December 31, 2018 (Kaiser Family 
Foundation, 2018). 
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Table 1            
Study Inclusion States and their Medicaid Expansion Status 
State Medicaid Expansion 
(as of 12/31/2018) 
Comments 
Maryland Yes  
Ohio Yes  
Pennsylvania Yes  
West Virginia Yes  
Georgia No  
North Carolina No  
Tennessee No  
Virginia No Medicaid Expanded on 
January 1, 2019 
 
Definitions 
30-day Mortality rate: The rate of death within 30 days of entering the hospital 
with a given condition (Medicare.gov, n.d.). 
Acute Myocardial Infarction (AMI): A sudden onset heart attack “when there is 
evidence of myocardial necrosis in a clinical setting consistent with acute myocardial 
ischemia” (Thygesen et al., 2012, p. 1584). 
Affordable Care Act (ACA): The U.S. healthcare law enacted in March of 2010 
(HealthCare.gov, n.d.). 
Center for Medicare and Medicaid Services (CMS): The federal agency 
designated to administer the U.S. Medicare program and assist states with the Medicaid 
program (CMS.gov, 2006). 
Chronic Heart Failure (CHF): A condition that is present when a patient exhibits 
symptoms of heart failure over a period of time (Ponikowski et al., 2016). 
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Hospital Compare: Hospital Compare “is a consumer-oriented website that 
provides information on how well hospitals provide recommended care to their patients” 
(CMS.gov, 2016, p. 1). 
Leapfrog Group (Leapfrog): A nonprofit organization that provides hospital data 
for the purpose of informing the public to help facilitate value-based purchasing using 
hospital grades (The Leapfrog Group, n.d.) 
Licensed beds (size): The number of patient beds that a hospital is allowed to 
operate (Agency for Healthcare Research and Quality, 2005).  The larger the number of 
beds is a good approximation of relative hospital size. 
Medicaid:  A healthcare program to help with medical costs for individuals with 
low and limited income that is comanaged by states and the federal (CMS.gov, 2006). 
Medicaid expansion: A designation for states that have selected to provide 
Medicaid coverage to citizens that are within 138% of the federal poverty level as 
allowed by the ACA (Kaiser Family Foundation, 2018). 
Ownership type: A designation that indicates if a hospital is a for-profit, not-for-
profit, government (nonfederal), or federal organization (Zhao, Haley, Spaulding, & 
Balogh, 2015). Federally managed hospitals are excluded from this study. 
Pneumonia: An infection of the lungs that causes the lung sacs, alveoli, to fill 
with fluid and inhibit the normal gas exchange process leading to difficulty in breathing 
(Prina, Ranzani, & Torres, 2015). 
Safety-net hospital: A designation for hospitals that provide a disproportionate 
share of healthcare to low-income individuals (Gilman et al., 2014). 
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State of Residency: The state in which the physical hospital is located. 
Teaching Status: “A hospital is considered a teaching hospital if it has one or 
more Accreditation Council for Graduate Medical Education (ACGME) approved 
residency program, is a member of the Council of Teaching Hospitals (COTH) or has a 
ratio of full-time equivalent interns and residents to beds of .25 or higher” (Healthcare 
Cost and Utilization Project, 2008, p. 1). 
Assumptions 
It is assumed that the 30-day mortality rates used in this study, as collected by 
CMS and presented in their hospital compare data, are accurate.  Furthermore, it is 
assumed that the CMS data, which are derived from only Medicare patients 65 years old 
and older (Medicare.gov, n.d.), is an accurate predictor of population health outcomes for 
those that fall below the eligibility age.  However, the CMS dataset is the only 
consistently reported hospital performance information available for comparing US 
hospitals. 
 It is also assumed that the variables are independent of each other.  This includes 
the method, as described above, in which the Leapfrog grade is calculated from the 
hospital safety data.  It is important for the statistical analysis that all variables are 
independent. 
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Limitations 
 Since the 30-day mortality rates are derived from Medicare patient data, it is a 
known limitation of this data that the data is only predictive of patients that are 65 years 
or older (Burke et al., 2017). 
 The Leapfrog grades are derived from both self-reported questionnaires for 
participating hospitals and from CMS data for those that do not choose to participate 
(Austin et al., 2014). 
 The analysis was limited to only those organizations that had adequate data 
elements.  Organizations that did not complete an AHA survey, have a Leapfrog grade, 
and at least one dependent variable, were eliminated from the study. 
 The results of this research only apply to the eight states studied and may not be 
conveyable to other U.S. states. 
Scope and Delimitations 
 The scope of this study was limited to the use of comparing the Leapfrog grades 
presented on The Leapfrog Group website for each hospital, AHA hospital data, and 
Hospital Compare.  All secondary data was extracted from publicly available datasets and 
analyzed as presented from the various organization without manipulation or 
interpretation.   
Significance of Study 
This study explored the linkage between publically available Leapfrog grades and 
patient outcomes.  I was able to demonstrate an inconsistent association between 
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leapfrog's consumer-accessible Hospital Safety Grades and included 30-day mortality 
rates. Therefore, Leapfrog grades were demonstrated to be an unreliable indicator from 
which consumers can use to select their healthcare provider on the basis of the analyzed 
outcomes. The study was also able to provide information on how the included covariates 
were associated with each outcome.  
Significance to Practice 
 Medicine is the art of healing and preventing illness.  However, the vast majority 
of quality measures are not outcome based.  Of the nearly 2,000 quality indicators in the 
National Quality Measures Clearinghouse, only 7% (139) are based on patient outcomes 
(Porter, Larsson, & Lee, 2016).  However, improved patient outcomes, specifically 
decreases in mortality rates, are the ultimate end goal of medicine.  While the authors 
discussed that mortality is rare and may not be a good differentiator among hospitals as a 
performance indicator, mortality is an important, and arguably the most important, 
outcome measure (Porter, Larsson, & Lee, 2016). The CMS data does exist to allow for 
determining significant differences among hospital data, regardless if mortality is a rare 
event among all hospitals. 
 Researching the linkage between Leapfrog grades and CMS available outcome 
measures for pneumonia, CHF, and AMI may help determine if correlations exists.  
Significance to Social Change 
This study provided healthcare consumers with the information needed to 
determine the usefulness of available Leapfrog grades for reliably predicting individual 
hospital patient outcomes for pneumonia, CHF, and AMI.  Furthermore, healthcare 
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organizations will be able to use the data to understand how their organizational attributes 
(e.g., ownership type) may impact patient outcomes and begin to make enhancements to 
increase their levels of care. 
Summary and Conclusion 
 The U.S. healthcare system has been undergoing a change in which consumers 
demand safe quality care that provides a positive customer experience.  As the U.S. 
healthcare system becomes more consumer-focused and driven, it is essential that 
consumers have the information necessary to make informed health decisions.  These 
decisions are not only about which type of treatments and medications they wish to 
partake but also which organization in which they wish to receive their care.  Leapfrog, 
using a proprietary safety grade calculation, is designed to give hospitals an A, B, C, D, 
or F grade (to match traditional school grades) to easily convey to consumers the safety 
and quality of care provided for a given hospital.  While this is admirable, the grades 
given to each hospital have the potential to impact the financial health of each 
organization.  Therefore, it is imperative that the grades be truly indicative of the care 
provided and devoid of biases towards a particular subset of hospitals.  This study was 
designed to ascertain if there is a correlation between Leapfrog scores and 30-day 
mortality rates. Furthermore, using the described covariates, the analysis was completed 
to determine if organizational descriptors demonstrate a grading bias. 
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Section 2: Research Design and Data Collection 
Introduction 
 Section 1 provided the rationality and historical validity for determining if a 
correlation is evident between the publicly available Leapfrog grades (independent 
variables) and the 30-day mortality rates for CHF, AMI, and pneumonia (dependent 
variables) data extracted from the CMS dataset.  It was demonstrated that further 
stratifying the data across the covariates is also supported by the literature.  The use of 
the covariates provides a foundation for determining if the Leapfrog grades demonstrate 
bias at a level that is statistically significant (p < 0.05).  Section 2 provides the research 
design, data collection, and analyses of the variables and covariates. 
Purpose of the Study 
The primary purpose of this study was to determine if Leapfrog hospital grades 
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS data 
from hospitals with other elements from eight states (GA, MD, OH, NC, PA, TN, VA, 
and WV) similar to Leapfrog focused studies (Pakyz et al., 2017).  While other studies 
have looked at the relationship between an organization’s financial performance and 
CHF, AMI, and pneumonia mortality rates (Nguyen et al., 2016), this study is unique in 
that I examined the information available to consumers on which they base their 
healthcare purchasing decisions. Secondarily, a comparison of the linear regressions 
derived from each organization’s grade was used to determine if the hospital safetey 
grade is predictive of the 30-day mortality data. Since the most significant measure of a 
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healthcare organization’s quality is patient outcomes (e.g., mortality rates), by performing 
a retrospective analysis one can compare if the rating organization’s provided healthcare 
grades are correlated with hospitals that have better patient outcomes. Additional 
stratifications using covariates of hospital-level quality data and descriptors (e.g., 
ownership type) were used to look for relationships, using regression analysis, and biases 
that may exist between the grades and other independent variables. 
Research Design and Rationale 
 This study used an inductive relational correlation theoretical approach that is 
described by Eisenhardt, Graebner, and Sonenshein (2016) to analyze the data.  This 
approach is appropriate for determining if the data are predictive in determining if an 
association exists between the independent variables (Leapfrog grades and descriptive 
characteristics) and the dependent variables (30-day mortality rates). Specifically, the 
three dependent variables used for determining correlations will consist of pneumonia, 
CHF, and AMI 30-day mortality rates derived from publicly available CMS data.   
The study was built upon similar studies that also looked to correlate the 
predictability of publicly available health scores/grades and quality indicators. One 
similar study sought to determine a relationship between Leapfrog scores and hospital-
acquired infections (Pakyz et al., 2017) and provide an approach that was used for this 
study.   
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Research Questions and Hypotheses 
RQ1: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with the CMS pneumonia mortality rate data adjusting for each 
covariate: licensed beds, ownership type, state of residency, safety net hospital status, 
state Medicaid expansion status, and organization’s teaching status? 
H11: The available consumer available health organization’s Leapfrog grade is 
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed 
beds, ownership type, state of residency, safety net hospital status, state Medicaid 
expansion status, and organization’s teaching status. 
H01: There is no correlation between Leapfrog grades and patient health mortality 
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership 
type, state of residency, safety net hospital status, state Medicaid expansion status, and 
organization’s teaching status. 
RQ2: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS congestive heart failure (CHF) patient mortality rate 
data adjusting for each covariate: licensed beds, ownership type, state of residency, safety 
net hospital status, state Medicaid expansion status,  and organization’s teaching status? 
H12: The available consumer available health organization’s Leapfrog grade is 
predictive of patient chronic heart failure (CHF) mortality rate data adjusting for each 
covariate: licensed beds, ownership type, state of residency, safety net hospital status, 
state Medicaid expansion status, and organization’s teaching status. 
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H02: There is no correlation between Leapfrog grades and patient mortality rates 
based on CHF data adjusting for each covariate: licensed beds, ownership type, state of 
residency, safety net hospital status, state Medicaid expansion status, and organization’s 
teaching status. 
 RQ3: Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality 
rate data adjusting for each covariate: licensed beds, ownership type, state of residency, 
safety net hospital status, state Medicaid expansion status,  and organization’s teaching 
status? 
H13: The available consumer available health organization’s Leapfrog grade is 
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed 
beds, ownership type, state of residency, safety net hospital status, state Medicaid 
expansion status, and organization’s teaching status. 
H03: There is no correlation between Leapfrog grades and patient health mortality 
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership 
type, state of residency, safety net hospital status, state Medicaid expansion status, and 
organization’s teaching status. 
Study Population Estimates 
 Acute care hospitals from eight states (GA, MD, NC, OH, PA, TN, VA, and WV) 
that contain required data elements (Table 2) were included.  To be included, each 
hospital had to have the following minimum data elements: Fall 2018 Leapfrog grade, at 
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least one of the three 30-day mortality rates, determined safety-net status, and all AHA 
survey elements. 
Table 2  
Required Data Elements for Study Inclusion 
Independent Variables 
 
Data Element Source 
Leapfrog grades 2018 Leapfrog Hospital Safety Grades 
Dependent Variables 
 
Pneumonia 30-day mortality rate CMS.gov 
CHF 30-day mortality rate CMS.gov 
AMI 30-day mortality rate CMS.gov 
Covariates 
 
Safety-net status CMS.gov (DSH payments) 
Ownership Type 2017 AHA Survey (ahadataview.com) 
Teaching status 2017 AHA Survey (ahadataview.com) 
Licensed beds (size) 2017 AHA Survey (ahadataview.com) 
State of residency 2017 AHA Survey (ahadataview.com) 
Medicaid expansion Kaiser Family Foundation (KFF.org) 
 
Estimated Sample Size 
 Table 3 provides the number of acute hospitals that in each state that received 
grades by the Leapfrog Group using the Fall 2018 dataset.  The total number of available 
hospitals was 590.  However, the numbers were reduced when additional data elements 
were found to be missing from the various datasets. 
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Table 3 
Number of Acute Care Hospitals Available for Study (per State) 
State Medicaid Expansion 
(as of 12/31/2018) 
Number of graded 
hospitals 
Maryland Yes 40 
Ohio Yes 110 
Pennsylvania Yes 132 
West Virginia Yes 24 
Georgia No 74 
North Carolina No 79 
Tennessee No 65 
Virginia No 66 
 
Power Analysis 
 An a priori power analysis was performed using G*Power (Version 3.1.9.2) to 
determine if the number of hospitals included in the study would be sufficient to detect a 
significant difference at a small effect size (f2 = .02).  With an α = 0.05 and at 80% 
predictive power, the minimum number of hospitals was 395 (Table 4).  The small effect 
size was selected due to the expected small difference among facilities and mortality 
rates.  The 80% predictive power was selected to give a minimum lower level.  However, 
based on the final sample sizes, all levels were > 85%.  There were 468 hospitals 
included for AMI mortality rates.  Pneumonia and CHF mortality rates each had 522 
hospitals analyzed.  The study exceeded the a priori minimum power to detect any 
differences that exist.  
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Table 4 
A Priori Predicted Study Size Calculation 
Inputs: Tail(s) 2 
Effect size (f2) 0.02 
α value 0.05 
Power 0.80 
Number of predictors        8 
Outputs: Sample size 395 
Actual power 0.8006 
 
Secondary Data Types and Sources of Information  
 The data for each hospital was obtained from the Hospital Compare website at 
CMS.gov, the AHA Annual survey data obtained from the AHA website, and the 
Leapfrog website.  Table 2 details which elements are derived from which source. 
Data Collection and Management 
 All data for this study was obtained from publicly available datasets. No patient or 
other protected information was utilized.  All data were downloaded directly from the 
various sources and kept on both my personal computer and backed-up using cloud 
storage. 
Study Analytical Strategies  
This study used linear regression analysis modeling to determine if statistically 
significant correlations exist between the three dependent variables patient outcomes 
(pneumonia, CHF, and AMI) and the independent variables while adjusting for each 
covariate (licensed beds, ownership type, state of residency, safety-net hospital status, 
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state Medicaid expansion status, organization’s safety net designation, and organization’s 
teaching status).   
All data were analyzed using SPSS (version 25) with the data tables imported 
from Microsoft® Excel®.  A Means analysis for each independent-dependent 
combination was performed using the Compare Means tool. Multiple regressions were 
run using the Regression tool. 
Initial Significance Modeling: Means Analysis 
Each independent was analyzed using the Means test to check for statistical 
significance that may exist with each dependent variable before inclusion in the multiple 
regression analysis for each dependent variable. The a priori acceptable level of 
significance was set at p < .05.  Eta Square (η2) value was used to demonstrate the 
strength of the association between each independent–dependent variable Means analysis.  
For all categorical data elements (Table 5), dummy variables were utilized to allow for 
regression analysis.  Each independent was analyzed using the Means test to check for 
statistical significance that may exist with each dependent variable before including the 
independent variables in the multiple regression analysis. 
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Table 5 
Data Type for Each Study Variable 
Data Element                                                       Data Type 
Independent Variables 
 
Leapfrog grades Categorical: A, B, C, D, or F 
Dependent Variables 
 
Pneumonia 30-day mortality rate Continuous 
CHF 30-day mortality rate Continuous 
AMI 30-day mortality rate Continuous 
Covariates 
 
Safety-net status Categorical (dichotomous): Yes or No 
Ownership Type Categorical: for-profit, not-for-profit, 
or public 
Teaching status Categorical: Major, Minor, or non-
teaching 
Licensed beds (size) Continuous 
State of residency Categorical: GA, MD, NC, OH, PA, 
TN, VA, and WV 
Medicaid expansion Categorical (dichotomous): Yes or No 
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Multiple Regression Analysis 
 Three multiple regression analyses were performed, one for each dependent 
variable.  An a priori p < .05 was used to determine if the model exhibited statistical 
significance.  The unstandardized β was analyzed to determine the effect size of each 
included independent variable.  The adjusted R2 was utilized to determine the strength of 
the model.  VIF score of  > 5 was utilized for determining collinearity among the 
independent and covariate variables.  Any data element that demonstrated 
multicollinearity, using VIF or tolerance, was removed from the final regression. 
Threats to Validity 
 Leapfrog grades are calculated by using either hospital supplied data or captured 
from Medicare publicly available data.  The validity of the data provided to Leapfrog 
from each participating organization is not able to be checked to ensure the values are 
valid during this study. 
Ethical Considerations 
 I will not have contact with any organization the compiled and supplied the 
publicly available datasets (e.g., Leapfrog).  There was no primary data collected for this 
study.  The Walden University institutional review board was consulted and approval 
granted before any research was conducted.  
Summary 
 In Section 2, I provided the proposed study design and data collection methods 
used for determining a correlation between Leapfrog grades and 30-day mortality rates.  
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Additional analysis was performed to determine if any of the indicated covariates 
demonstrate any statistically significant correlations.  Furthermore, data collecting, 
handling, and analysis have also been provided to help ensure all results derived from this 
study are valid. Lastly, possible data threats and ethical concerns were addressed.  
  
36 
 
 
 
Section 3: Presentation of the Results and Findings 
Introduction 
 The primary purpose of this study was to determine if Leapfrog hospital grades 
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS data 
from hospitals with other elements from eight states (GA, MD, OH, NC, PA, TN, VA, 
and WV) similar to Leapfrog focused studies (Pakyz et al., 2017).  In this section, the 
data collection methods, data selection criteria, data analysis methodologies, and a 
summary of the statistical results are presented.  The final number of hospitals that were 
included in the study was 524 with no individual dependent variable having more than 
522 hospitals.  To be included, each hospital had to have the following minimum data: 
Leapfrog grade, at least one of the three 30-day mortality rates, determined safety-net 
status, and all AHA survey elements. 
Secondary Data Element Collection 
Leapfrog Hospital Safety Grades 
 The Fall 2018 Leapfrog Hospital Safety Grades were the most currently available 
when the data was collected from the Leapfrog Group’s website in December 2018.  For 
each state included in the study (GA, MD, OH, NC, PA, TN, VA, and WV), the selection 
was made for search by state and the state was entered.  This process allowed for the 
propagation of a listing of all hospitals within each state.  The list consisted of the 
hospital’s name, the hospital’s address, and their corresponding safety grade.  Each 
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hospital name and corresponding grade was entered into an Excel® spreadsheet.  There 
were 590 individual hospital entries (see Table 3 for distribution by state). 
30-Day Mortality Rates (AMI, CHF, and Pneumonia) 
 The CMS 30-day mortality rate data was recovered from the CMS.gov website. 
The dataset was downloaded as an Excel® file to allow for appropriate sorting.  The data 
were sorted by state and placed in alphabetical order.  All data elements that did not 
pertain to the 30-day mortality rate information were eliminated, along with the states not 
included in this study.  Each Leapfrog hospital had its results manually entered for AMI, 
CHF, and pneumonia 30-day mortality rates.  Hospitals were matched by facility name 
and address.  However, when the hospital names did not match, the address of the facility 
was used to ensure the facilities were indeed the same.  Of the 590 hospitals with 
Leapfrog grades, 30-day mortality rates were available for 79.3% (n=468) for AMI, 
88.5% (n=522) for CHF, and 88.5% (n=522) for pneumonia. 
 Table 6 presents the mortality rates for each dependent variable.  It is important to 
note, and will be used later, the spread of the values among the hospitals for each 
dependent variable (AMI=8.6, CHF=10.3, and pneumonia=12.2). The greater the 
variability of each mortality rates among the hospitals increases the possibility of 
discovering statistical differences among hospitals. 
AHA Data Elements (Teaching Status, Number of Beds, and Ownership Type) 
 Each hospital with a Leapfrog grade had their AHA survey data accessed through 
the Health Forum website (ahadataviewer.com) in December 2018 – January 2019.  
Health Forum is an affiliate of the AHA and provides access to AHA survey data.  An 
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attempt was made to find the AHA survey data for each of the 590 Leapfrog hospitals. 
An information sheet for each hospital was printed using the “Free Hospital Look-Up” 
feature.  AHA survey data was found for 90.3% (n=533) of the Leapfrog hospitals.  The 
57 hospitals without verifiable AHA data were eliminated from the study. All relevant 
data elements were manually entered into the data collection spreadsheet. 
Safety-Net Status 
 Safety-net status was derived from the “CMS DSH Payment Percentages” found 
on CMS.gov on January 4, 2019.  The percentage of DSH payments, as reported by each 
hospital, varied between November 2015 and September 2017.  Each state’s percentages 
were sorted from highest to lowest.  The top quartile from each state was designated as a 
safety-net hospital regardless of whether the hospitals were included as part of the study.  
The sorting of all hospitals allowed for an accurate ranking of the state’s safety-net 
hospitals.  When there was a tie among hospitals for the final quartile position, all 
hospitals with that DSH payment percentage were included as a safety-net hospital.  Each 
hospital’s safety-net designation manually loaded into the spreadsheet as a dichotomously 
coded variable (1 =Yes, 0 =No).  Because a disproportionate share of safety-net hospitals 
had Leapfrog scores, at least one CMS mortality rate, and AHA survey data (n=533), 
43.4% (n=232) of hospital included in the study were designated as safety-net, and 56.6% 
(n=302) were not safety-net. 
Medicaid Expansion 
 Each of the study’s eight state’s Medicaid expansion status was through 
December 31, 2018.  The status of each state was derived from the Kaiser Family 
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Foundation’s website (KFF.org).  Each hospital’s Medicaid expansion designation 
manually loaded into the spreadsheet as a dichotomously coded variable (1 =Yes, 0 =No). 
State 
 Each hospitals state was loaded into the dataset as extracted from the Leapfrog 
database and confirmed using both the CMS and AHA datasets.  There were no 
discrepancies found within the dataset when determining the state in which each hospital 
is physically located. 
Descriptive Statistics 
 The descriptive statistics for each dependent variable are listed in Table 6.  The 
scores for AMI mortality rates: n=468, =13.20, SD=1.15, minimum=10.1, and 
maximum=18.7; CHF mortality rates: n=522, =11.57, SD=1.64, minimum=6.7, and 
maximum=17.0; pneumonia mortality rates: n=522, =16.07, SD=2.00, minimum=11.3, 
and maximum=23.5.  Figures 2-4 demonstrate that each dependent variable is normally 
distributed around the mean. 
Table 6 
Descriptive Statistics for Dependent Variables 
Variable n Min Max Mean SD 
AMI 30-Day 
Mortality Rate 
468 
 
10.1 18.7 13.20 1.15 
CHF 30-Day 
Mortality Rate 
522 6.7 17.0 11.57 1.64 
Pneumonia 30-Day 
Mortality Rate 
522 11.3 23.5 16.07 2.00 
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Figure 2: AMI 30-day mortality rate distribution 
 
 
Figure 3: CHF 30-day mortality rate distribution 
 
 
Figure 4: Pneumonia 30-day mortality rate distribution 
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The descriptive statistics for each independent variable are listed in Table 7.  It is 
notable that for the Leapfrog grades, that none of the 524 included hospitals received an 
“F” for the Fall 2018 grades.  The Leapfrog grades were distributed as such: 37.2% 
received an “A” (n=195), 24.4% received a “B” (n=128), 33.0% received a “C” (n=173), 
and only 5.3% received a “D” (n=28).  With the absence of any “F” grades, the 
distribution of Leapfrog grades is skewed heavily to the left and does not demonstrate a 
normal distribution.  
Safety-net hospital status (“Yes” =43.7%, “No” =56.37%) and Medicaid 
expansion (“Yes” =51.9%, “No” =48.1%) were nearly equally distributed.  The 
distribution of teaching status (Major =10.7%, Minor =50.4%, Nonteaching =38.9%) and 
ownership type (Not-For-Profit =78.2%, For-Profit =12.4%, Public =9.4%) were not 
equally distributed and demonstrated that a strong propensity towards minor teaching 
status and not-for-profit status.  The distribution of hospitals among the eight states (PA 
=21.4%, OH =18.7%, NC =13.7%, GA =13.0%, VA =11.6%, TN=9.7%, MD =7.4%, 
WV =4.4%) demonstrate a distribution that very closely resembled each states 
population. 
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Table 7 
Descriptive Statistics for Independent Variables 
Variable n % 
Leapfrog Grades   
A 195 37.2% 
B 128 24.4% 
C 173 33.0% 
D 28 5.3% 
F 0 0.0% 
Safety-Net Hospital   
Yes 229 43.7% 
No 295 56.3% 
Medicaid Expansion   
Yes 272 51.9% 
No 252 48.1% 
State   
GA 68 13.0% 
MD 39 7.4% 
NC 72 13.7% 
OH 98 18.7% 
PA 112 21.4% 
TN 51 9.7% 
VA 61 11.6% 
WV 23 4.4% 
Teaching Status   
Major 56 10.7% 
Minor 264 50.4% 
Non-Teaching 204 38.9% 
Ownership Type   
Not-For-Profit 410 78.2% 
For-Profit 65 12.4% 
Public 49 9.4% 
Licensed Bed Groupings   
<100 111 21.2% 
100 – 199 151 28.8% 
200 – 499 189 36.1% 
>500 73 13.9% 
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Study Results 
 After completing the collection, collating, and description of the data elements for 
each hospital, the SPSS Means comparison test was performed with each independent 
variable to test significance with each dependent variable.  The Means test was done to 
ensure that only independent variables that demonstrated significance (p < .05) were 
included in the multiple regression analyses. 
 The multiple regression modeling for each dependent variable was performed 
using indicator, or dummy, variables for the noncontinuous independent variables 
(Leapfrog grade, state, teaching status, ownership type, and groupings of bed size).  For 
dichotomous independent variables (safety-net and Medicaid expansion) the data was 
entered using binary coding (yes = 1 and no = 0).  The reference value for each set of 
indicator variables used for the multiple regression analysis was: Leapfrog grade – “A,” 
state – Virginia, teaching status – major, ownership type – not-for-profit, and groupings 
of bed size – small (< 100 beds). 
Research Question #1: Pneumonia Data 
 RQ1. Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with the CMS pneumonia mortality rate data adjusting for each 
covariate: licensed beds, ownership type, state of residency, safety net hospital status, 
state Medicaid expansion status, and organization’s teaching status? 
 Means comparison testing.  Using the ANOVA results from the Means 
comparison test, Table 8 depicts that Leapfrog grades (p=.042), Medicaid expansion 
(p<.001), state (p<.001), teaching status (p<.001), and ownership type (p<.001) all 
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demonstrated statistical significance with 30-day pneumonia mortality rates.  However, 
safety-net hospital status (p=.964) and number of beds (p=.360) failed to demonstrate 
statistical significance and were not included in the multiple regression analyses.   
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Table 8 
Means Comparison of Independent Variables and Pneumonia 30-Day Mortality Rates 
Variable n Mean SD p 
Leapfrog Grades    .042 
A 194 15.8 2.0  
B 127 16.3 2.0  
C 173 16.3 2.0  
D 28 15.9 1.4  
Safety-Net Hospital    .964 
Yes 228 16.1 2.0  
No 294 16.1 2.0  
Medicaid Expansion    <.001 
Yes 271 15.5 1.8  
No 251 16.6 2.0  
State    <.001 
GA 68 16.4 2.1  
MD 39 16.1 1.6  
NC 72 17.3 1.8  
OH 98 15.1 1.8  
PA 111 15.7 1.8  
TN 51 16.7 2.1  
VA 60 16.1 1.9  
WV 23 15.7 2.2  
Teaching Status    <.001 
Major 55 15.4 1.8  
Minor 264 15.9 1.9  
Non-Teaching 203 16.5 2.1  
Ownership Type    <.001 
Not-For-Profit 409 15.9 2.0  
For-Profit 64 16.8 2.0  
Public 49 16.8 2.0  
Licensed Bed Groupings    .360 
<100 111 16.3 1.9  
100 - 199 150 16.0 2.1  
200 - 499 189 16.1 2.0  
>500 72 15.7 2.0  
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Multiple regression analysis. The multiple regression analysis did not 
demonstrate multicollinearity, except for Pennsylvania, as all VIF values were < 3.50 and 
tolerance values were > .28.  Pennsylvania was excluded from the SPSS multiple 
regression analysis as the tolerance value (.000) demonstrated multicollinearity.  There 
was no indication of autocorrelation as the Durbin-Watson score was 1.96.  The model 
was statistically significant (p < .001) with an adjusted R2 = .132.   
Table 9 demonstrates that among the Leapfrog grades, all hospital grades 
demonstrated a deterioration (positive unstandardized β indicates an increase in the 
percentage of pneumonia deaths) compared those for “A” rated hospitals.  Only hospitals 
with a “C” grade (β = 0.513, p = .010) was statistically significantly different from the 
reference category (“B” = β = 0.358, p = .096; “D” = β = 0.250, p = .519).  However, the 
actual effect size, as a percentage of the range of pneumonia values (range = 12.2), 
demonstrated the effect was small and the actual differences among the grades were 
minimal (B = 2.9%, C = 4.2%, and D = 2.0%). 
Medicaid expansion did not demonstrate a statistically significant difference (p = 
.276) for 30-day pneumonia mortality rates between hospitals that reside in states that 
have or have not expanded Medicaid. 
Using Virginia as the reference category, only North Carolina (β = 1.156, p = 
.001) and Ohio (β = -0.524, p = .044) were significantly different for pneumonia 
mortality.  North Carolina’s effect size demonstrated a 9.5% increase and Ohio’s effect 
size indicated a 4.3% decrease in mortality rates.  Pennsylvania was eliminated from the 
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multiple regression analysis using SPSS due to the state demonstrating multicollinearity 
(tolerance = .000). 
Teaching status, using major teaching status as the reference category, non-
teaching status (β = 0.734, p = .012) demonstrated 6.0% worse outcomes and minor 
teaching status (β = 0.463, p = .098) just failed to exhibit statistical significance. 
There was a significant difference demonstrated among not-for-profit (reference 
category) and for-profit hospitals (β = 0.678, p = .011), but not for public hospitals (β = 
0.159, p = .610).  The effect size for the for-profit hospitals revealed a 5.6% increase in 
mortality rates. 
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Table 9 
Multiple Regression Analysis for Pneumonia 30-Day Mortality Rates (N=522) 
Variable Unstandardized 
β 
P VIF Tolerance 
Leapfrog Grades     
(A = reference category)     
B .358 .096 1.280 .781 
C .513 .010 1.328 .753 
D .250 .519 1.147 .872 
Medicaid Expansion -.331 .276 3.467 .288 
State     
(VA = reference category)     
GA .244 .469 1.934 .517 
MD .397 .258 1.283 .780 
NC 1.156 .001 2.100 .476 
OH -.524 .044 1.554 .644 
TN .312 .391 1.751 .571 
WV -.193 .656 1.189 .841 
PA – excluded variable    .000 
Teaching Status     
(Major = reference category)     
Minor .463 .098 2.940 .340 
Non-Teaching .734 .012 3.002 .333 
Ownership Type     
(Not-For-Profit = reference category)     
For-Profit .678 .011 1.141 .876 
Public .159 .610 1.237 .809 
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Research Question #2: CHF 
RQ 2. Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS congestive heart failure (CHF) patient mortality rate 
data adjusting for each covariate: licensed beds, ownership type, state of residency, safety 
net hospital status, state Medicaid expansion status, and organization’s teaching status? 
Means comparison testing.  Using the ANOVA results from the Means 
comparison test, Table 10 depicts that Medicaid expansion (p = .003), state (p = .001), 
teaching status (p = .003), ownership type (p = .001), and number of beds (p = .033) all 
demonstrated statistical significance with 30-day CHF mortality rates.  However, 
Leapfrog grades (p = .115) and safety-net hospital status (p = .159) failed to demonstrate 
statistical significance and were not included in the multiple regression analyses.   
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Table 10 
Means Comparison of Independent Variables and CHF 30-Day Mortality Rates 
Variable n Mean SD p 
Leapfrog Grades    .115 
A 194 11.5 1.6  
B 127 11.6 1.6  
C 173 11.8 1.7  
D 28 11.0 1.5  
Safety-Net Hospital    .159 
Yes 229 11.5 1.6  
No 293 11.7 1.6  
Medicaid Expansion    .003 
Yes 270 11.4 1.7  
No 252 11.8 1.5  
State    .001 
GA 68 11.6 1.6  
MD 39 10.9 1.8  
NC 72 12.1 1.3  
OH 97 11.3 1.8  
PA 111 11.5 1.5  
TN 51 12.2 1.6  
VA 61 11.3 1.5  
WV 23 11.6 1.8  
Teaching Status    .003 
Major 55 11.1 1.8  
Minor 263 11.4 1.7  
Non-Teaching 204 11.8 1.5  
Ownership Type    .001 
Not-For-Profit 409 11.4 1.6  
For-Profit 65 11.9 1.5  
Public 48 12.3 1.7  
Licensed Bed Groupings    .033 
<100 110 11.9 1.5  
100 - 199 151 11.6 1.6  
200 - 499 189 11.4 1.7  
>500 72 11.3 1.6  
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Multiple regression analysis. The multiple regression analysis, as seen in Table 
11, did not demonstrate multicollinearity for the tested variables, except for Medicaid 
expansion, as all VIF values were < 4.722 and tolerance values were > .211.  Medicaid 
expansion was removed from the SPSS analysis due to the demonstration of 
multicollinearity (tolerance = .000).  There was no indication of autocorrelation as the 
Durbin-Watson score was 2.085.  The model was statistically significant (p < .001) with 
the adjusted R2 = .049 revealing the model has a very weak relationship among the 
independent variables and CHF mortality rates.  
Using Virginia as the reference category, only North Carolina (β = 0.686, p = 
.020) and Tennessee (β = 0.761, p = .014) were significantly different for CHF mortality.  
Both states demonstrated increased CHF mortality rates (North Carolina = 6.7%, 
Tennessee = 7.4%) when compared to Virginia. 
When comparing teaching statuses, using major teaching status as the reference 
category, minor teaching status (β = 0.222, p = .431) nor non-teaching status (β = 0.358, 
p = .251) demonstrated statistical significance for CHF. 
There was a significant difference demonstrated among not-for-profit (reference 
category) and public hospitals (β = 0.543, p = .044); however, for-profit hospitals (β = 
0.253, p = .266) failed to exhibit statistical significance for CHF.  The β for public 
hospitals suggests a 5.3% increase in CHF mortality than the reference category.  
There was no statistically significant difference among hospitals with differences 
in the number of licensed beds using small, < 100 beds, as the reference category.  
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Medium, 100 – 199, (β = -0.338, p = .099), large, 200 – 499, (β = -0.339, p=.099), and 
very large, 500+, (β = -0.523, p = .079). 
Table 11 
Multiple Regression Analysis for CHF 30-Day Mortality Rates (N=522) 
Variable Unstandardized 
β 
P VIF Tolerance 
Medicaid Expansion –excluded variable    .000 
State     
(VA = reference category)     
GA .302 .292 1.901 .526 
MD -2.33 .485 1.577 .634 
NC .686 .020 2.101 .476 
OH .139 .601 2.177 .459 
PA .306 .236 2.279 .439 
TN .761 .014 1.727 .579 
WV .300 .445 1.326 .754 
Teaching Status     
(Major = reference category)     
Minor .222 .431 4.065 .246 
Non-Teaching .358 .251 4.721 .212 
Ownership Type     
(Not-For-Profit = indicator variable)     
For-Profit .253 .266 1.152 .868 
Public .543 .044 1.233 .811 
Licensed Bed Groupings     
(<100 = reference category)     
100 - 199 -.338 .099 1.756 .569 
200 - 499 -.339 .099 1.991 .502 
500+ -.523 .079 2.152 .465 
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Research Question #3: AMI 
RQ 3. Does an organization’s Leapfrog grade demonstrate a statistically 
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality 
rate data adjusting for each covariate: licensed beds, ownership type, state of residency, 
safety net hospital status, state Medicaid expansion status, and organization’s teaching 
status? 
Means comparison testing.  Using the ANOVA results from the Means 
comparison test, Table 12 depicts that Medicaid expansion (p < .001), state (p < .001), 
teaching status (p < .001), and ownership type (p < .001), all demonstrated statistical 
significance with 30-day AMI mortality rates.  However, Leapfrog grades (p = .345),  
safety-net hospital status (p = .395), and number of beds (p = .365) failed to demonstrate 
statistical significance and were not included in the multiple regression analyses.  
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 Table 12 
Means Comparison of Independent Variables and AMI 30-Day Mortality Rates 
Variable n Mean SD p 
Leapfrog Grades    .345 
A 172 13.1 1.2  
B 114 13.2 1.3  
C 157 13.3 1.1  
D 25 13.1 1.1  
Safety-Net Hospital    .395 
Yes 212 13.3 1.2  
No 256 13.2 1.1  
Medicaid Expansion    <.001 
Yes 239 12.9 1.1  
No 229 13.5 1.1  
State    <.001 
GA 60 13.5 1.2  
MD 35 13.0 1.0  
NC 69 13.5 1.1  
OH 81 12.7 1.1  
PA 100 12.9 1.1  
TN 42 13.7 1.3  
VA 58 13.4 0.9  
WV 23 13.3 1.1  
Teaching Status    <.001 
Major 55 13.2 1.5  
Minor 245 13.0 1.1  
Non-Teaching 168 13.5 1.1  
Ownership Type    <.001 
Not-For-Profit 371 13.1 1.1  
For-Profit 56 13.7 1.1  
Public 41 13.7 1.3  
Licensed Bed Groupings    .360 
<100 70 13.3 0.8  
100 - 199 139 13.2 1.1  
200 - 499 188 13.2 1.2  
>500 71 13.0 1.4  
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Multiple regression analysis. The multiple regression analysis, as seen in Table 
13, did not demonstrate multicollinearity, except for Pennsylvania, as all VIF values were 
< 3.27 and tolerance values were > .30.  Pennsylvania was excluded from the SPSS 
multiple regression analysis as the tolerance value (.000) demonstrated multicollinearity.  
There was no indication of autocorrelation as the Durbin-Watson score was 1.98.  The 
model was statistically significant (p < .001) with a weak adjusted R2 = .101.   
Medicaid expansion demonstrated that for hospitals in states that did not expand 
Medicaid, there was a 4.6% improvement (β = -0.396, p = .031) in AMI mortality rates 
when compared with those that did expand Medicaid. 
Using Virginia as the reference category, none of the states were significantly 
different for AMI mortality rates [GA (β = 0.114, p = .574), MD (β = 0.152, p = .481), 
NC (β = -0.004, p = .985), OH (β = -0.122, p = .458), TN (β = 0.182, p = .420), WV (β = 
0.320, p = .209)]. Pennsylvania was excluded from the SPSS multiple regression analysis 
as the tolerance value (.000) demonstrated multicollinearity. 
When comparing teaching statuses, using major teaching status as the reference 
category, minor teaching status (β = -0.238, p = .150) nor non-teaching status (β = 0.116, 
p = .505) demonstrated statistical significance for AMI. 
There was a significant difference demonstrated among not-for-profit (reference 
category) and for-profit hospitals (β = 0.392, p = .019), but not for public hospitals (β = 
0.384, p = .052).  The for-profit β indicated a 4.6% increase in AMI mortality rates. 
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Table 13 
Multiple Regression Analysis for AMI 30-Day Mortality Rates (N=468) 
Variable Unstandardized 
β 
P VIF Tolerance 
Medicaid Expansion -.396 .031 3.261 .307 
State     
(VA = reference category)     
GA .114 .574 1.815 .551 
MD .152 .481 1.256 .796 
NC -.004 .985 2.093 .478 
OH -.122 .458 1.514 .661 
TN .182 .420 1.619 .618 
WV .320 .209 1.184 .845 
PA – excluded variable    .000 
Teaching Status     
(Major = reference category)     
Minor -.238 .150 2.666 .375 
Non-Teaching .116 .505 2.737 .365 
Ownership Type     
(Not-For-Profit = reference category)     
For-Profit .392 .019 1.149 .870 
Public .384 .052 1.220 .820 
 
Summary 
 Above, the data analysis was presented for both the performed Means 
comparisons testing and multiple regression analysis for each dependent variable.  
Leapfrog Hospital Safety Grades do not reliably predict patient outcomes for 30-day 
patient mortality rates. The regression modeling demonstrated weak relationships for 
each dependent variable; however, the pneumonia model was the best at demonstrating 
predictable differences among the various independent variables.  Additional findings are 
that Medicaid expansion correlates with better outcomes for AMI (β = -0.396, p = .031, 
decrease of 4.6%), North Carolina has worse outcomes for both pneumonia (β = 1.156, p 
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= .001, increase of 9.5%)  and CHF (β = 0.686, p = .020, increase of 6.7%), Ohio has 
improved pneumonia outcomes (β = -0.524, p = .044, decrease of 4.3%), Tennessee has 
worse CHF outcomes (β = 0.761, p = .014, increase of 7.4%), non-teaching hospitals 
have poorer pneumonia outcomes (β = 0.734, p = .012, increase of 6.0%), For-Profit 
hospitals have worse outcomes for both pneumonia (β = 0.678, p = .011, increase of 
5.6%) and AMI (β = 0.392, p = .019, increase of 4.6%), while publicly owned facilities 
have worse outcomes for CHF (β = 0.543, p = .044, increase of 5.3%), when adjusting for 
other included covariates.  Overall, ownership type and selected states (e.g., North 
Carolina) was a significant predictor for two of the three dependent variables.  While 
most of the covariates provided some predictive value for at least one of the included 
outcomes, in most cases, the effect (β) was small.   
  
58 
 
 
 
Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
 The purpose of this research study was to determine if publicly available Leapfrog 
Hospital Safety Grades could be used by healthcare consumers to select hospitals with an 
expectation of improved 30-day mortality rates for pneumonia, CHF, and AMI. The data 
was also analyzed to determine if specified covariates were correlated with these same 
patient outcomes to further assist consumers with their healthcare choices. It is important 
that publically available healthcare ratings and information provided to healthcare 
consumers are accurate indications of the care provided. 
Interpretation of Results 
RQ1: Analysis  
 Leapfrog grades and pneumonia. Leapfrog grades are correlated with 30-day 
mortality rates for pneumonia (p = 0.42).  Therefore, the H01 is rejected, and H11 is 
accepted.  The Leapfrog grade does allow consumers to predict 30-day mortality 
outcomes for pneumonia, but with a very low level of association (η2 = .016) may lead to 
inaccurate predictions despite the acceptable level of statistical significance.  However, 
only between “A” and “C” grades were differences exhibited among the grades 
themselves (p = .010) and pneumonia mortality rates in the multiple regression model.  
The model itself exhibited a weak relationship (adjusted R2 = .132) between the included 
variables and dependent variable. 
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 Covariates and pneumonia.  When looking at the effect of the various covariates 
have on pneumonia mortality rates, there was a significant difference demonstrated for 
Medicaid expansion (p < .001), among the states (p < .001), teaching status (p < .001), 
and ownership type (p < .001), when analyzed as groups.   
When analyzing pneumonia mortality rates for Medicaid expansion, there is 
statistically no difference between states that have expanded Medicaid and those that 
have not (p = .276) when all significant covariates are analyzed as part of the multiple 
regression.  
The differences between Virginia (reference value) and North Carolina (β = 
1.156, p = .001) was statistically significant and demonstrated that North Carolina has a 
significantly higher mortality rate from pneumonia.  There was also a statistical 
difference demonstrated between Virginia and Ohio (β = -0.524, p = .044).  However, in 
this case, Ohio has lower mortality rates than Virginia.  The remaining did not 
demonstrate any statistical difference when compared to Virginia.  Therefore, there are 
statistically significant differences among states for pneumonia 30-day mortality rates. 
Teaching status did demonstrate a statistical difference between major teaching 
(reference category) and hospitals that are non-teaching (β = 0.734, p = .012).  These 
results demonstrate that non-teaching hospitals worse 30-day mortality rates for patients 
with pneumonia than those patients treated at major teaching hospitals. There was no 
difference, at the a priori p < .05 level, between major teaching and minor teaching (β = 
0.463, p = .098).  However, the differences are such that major teaching hospitals may do 
a better job of treating pneumonia, thus reducing the mortality rates, at least when 
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compared to non-teaching hospitals.  It is important to note that 84% of major teaching 
hospitals in this study are not-for-profit organizations.  Therefore, the linkage between 
major teaching status and ownership type might explain a lot of the effect being 
demonstrated in both categories. 
Ownership type demonstrated a significant difference among not-for-profit 
(reference category) and for-profit hospitals (β = 0.678, p = .011), but not for public 
hospitals (β = 0.159, p = .610).  The data demonstrated that not-for-profit hospitals do 
have a 5.6% decrease in pneumonia mortality than for-profit hospitals.  
RQ2: Analysis  
 Leapfrog grades and CHF. Leapfrog grades were found not to be correlated 
with 30-day mortality rates for CHF (p = .115).  Leapfrog grades had a very weak 
association (η2 = .011) with CHF mortality rates.  Therefore, the H02 cannot be rejected, 
and must be is accepted.  The Leapfrog grades are not a reliable tool for consumers to 
predict 30-day mortality outcomes for CHF.  The lack of correlation between a hospital’s 
Leapfrog grade and patient CHF outcomes is a significant finding and will be discussed 
further. 
 Covariates and CHF.  When looking at the effect of the various covariates have 
on CHF mortality rates, there was significant difference demonstrated for Medicaid 
expansion (p = .003), state (p = .001), teaching status (p = .003), ownership type (p = 
.001), and number of beds (p = .033). The only covariate that failed to demonstrate 
statistical significance for 30-day CHF mortality rates was safety-net hospital status (p = 
.159).  It is important to note that the model demonstrates a weak relationship (adjusted 
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R2 = .050) as almost none of the variance in the dependent variable is explained by the 
independent variables. 
 Medicaid expansion, while being correlated with CHF outcomes, was unable to 
be used as part of the multiple regression analysis due to multiple collinearity (tolerance 
= .000), and was excluded from the analysis by SPSS.  However, it is still notable that 
Medicaid expansion is correlated with CHF outcomes, and can be used a predictor. 
When compared individually to Virginia, North Carolina (β = 0.686, p = .020) 
and Tennessee (β = 0.761, p = .014) both demonstrated worse 30-day outcomes for 
patients with CHF.  While none of the other states demonstrated a statistically 
significance when compared to Virginia, the analysis demonstrates that there are 
significant differences among states and CHF outcomes. 
Teaching status failed to demonstrate any difference among hospitals for patient 
outcomes for CHF using major teaching status as the reference category.  The individual 
comparison between major teaching and both minor teaching (β = 0.222, p = .431) and 
non-teaching (β = .358, p = .251) hospitals did not have either value even approach 
significance. 
Ownership type, using not-for-profit as the reference category, demonstrated a 
significant difference with public hospitals (β = 0.543, p = .044); however, for-profit 
hospitals (β = .253, p = .266) did not demonstrate any such difference.  Therefore, not-
for-profit hospitals do demonstrate significantly better outcomes for CHF than public 
hospitals. 
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All hospitals sizes [Medium, 100 – 199, (β = -0.338, p = .099), large, 200 – 499, 
(β = -0.339, p = .099), and very large, 500+, (β = -0.523, p = .079)] demonstrated 
improved CHF mortality rates when compared to small hospitals at the p < 0.1 level.  
However, the a priori significance level for this study was established at p < .05; 
therefore, none of the numbers are considered to be statistically significant for this study.  
RQ3: Analysis  
 Leapfrog grades and AMI. Leapfrog grades were found not to be correlated 
with 30-day mortality rates for AMI (p = .345). Leapfrog grades had an extremely weak 
association (η2 = .007) with AMI mortality rates.  Therefore, the H03 cannot be rejected, 
and must be is accepted.  The Leapfrog grades are not a reliable tool for consumers to 
predict 30-day mortality outcomes for AMI.  The lack of correlation between a hospital’s 
Leapfrog grade and patient AMI outcomes is a significant finding and will be discussed 
further. 
Covariates and AMI.  When analyzing the effect of the various covariates, using 
Means comparison, on AMI mortality rates, there was significant difference 
demonstrated for Medicaid expansion (p < .001), state (p < .001), teaching status (p < 
.001), and ownership type (p < .001). Safety-net status (p = .395) and number of beds (p 
= .360) failed to demonstrate statistical significance for 30-day AMI mortality rates.  In 
addition, the model demonstrated a weak relationship (adjusted R2 = .101) as most of the 
variance in the dependent variable is not explained by the independent variables. 
Medicaid expansion results demonstrated that patients in states without Medicaid 
expansion (β = 0.396, p = .031) had worse 30-day mortality rates for AMI than those 
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states that did expand Medicaid.  The reasons for improved patient outcomes for patients 
in states with Medicaid expansion are outside the scope of this study but may warrant 
further study. 
State comparisons with Virginia demonstrated that the various states did not 
demonstrate any statistical differences for AMI mortality rates.  While there was a 
correlation for the states, when taken as a whole, and AMI outcomes, there was no 
difference when the states were compared to Virginia.  However, this does not mean, if a 
different state was used as a reference category, that some differences in AMI results 
would not be demonstrated. 
When comparing teaching statuses, using major teaching status as the reference 
category, minor teaching status (β = -0.238, p = .150) nor nonteaching status (β = 0.116, 
p = .505) demonstrated statistical significance for AMI.  Therefore, while teaching status 
can be correlated with AMI mortality rates, when the results are compared to major 
teaching status, there are no statistical differences observed.  There might be differences 
seen if a different reference category was utilized.  
There was a significant difference demonstrated among not-for-profit (reference 
category) and for-profit hospitals (β = 0.392, p = .019). However, public hospitals (β = 
0.384, p = .052) just failed to exhibit statistical significance when compared to the 
study’s a prior p-value of < .05.  In each case, both for-profit and public had worse 
patient outcomes for AMI mortality rates.  Future studies that include all 50 states might 
be able to further elucidate the strength of the relationship between ownership type and 
AMI mortality rates.   
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Limitations of the Study 
Since the 30-day mortality rates are derived from Medicare patient data, it is a 
known limitation of this data that the data is only predictive of patients that are 65 years 
or older (Burke, Frakt, Khullar, Orav, & Jha, 2017).  In addition, Leapfrog grades are 
derived from both self-reported questionnaires for participating hospitals and from CMS 
data for those that do not choose to participate (Austin et al., 2014).  The analysis was 
limited to only those organizations that had adequate data elements.  Organizations that 
did not complete an AHA survey, have a Leapfrog grade, and at least one dependent 
variable, were eliminated from the study. Finally, the results of this research only apply 
to the eight states studied and may not be conveyable to other US states. 
 
Recommendation  
 The study demonstrated, within the stated limitations, that Leapfrog Hospital 
Safety Grades are not particularly useful for consumers to utilize if selecting a care 
provider expecting different mortality rates for the hospitals included.  Therefore, 
Leapfrog Hospital Safety Grades should not be used to differentiate hospitals for patient 
outcomes. The data did demonstrate that some hospital characteristics could be utilized as 
predictors of potential patient outcomes, especially with pneumonia 30-day mortality 
rates, within the eight US states that were included.  It is recommended that this study is 
expanded to include all 50 US States to ensure a regional bias is not being demonstrated.  
Furthermore, the expansion to all 50 States would help account for variabilities that may 
exist among regions and populations. 
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Implications for Professional Practice and Social Change 
The study was able to demonstrate that healthcare consumers cannot rely upon 
Leapfrog grades to predict differences among hospitals for 30-day mortality rates for 
pneumonia, CHF, and AMI.  The demonstration of the lack of linkage should cause 
healthcare consumers to look for other possible indicators for predicting outcomes.  The 
study also provided a connection between various hospital descriptors (selected states, 
ownership type, and teaching status) that demonstrated that efforts to reduce 30-day 
mortality rates, especially for pneumonia, can be targeted for improvement. 
 
Professional Practice 
 Healthcare continues to become more customer focused, and the amount of 
available quality information is also expanding to provide consumers with the 
information to select their healthcare providers (Scanlon, Shi, Bhandari, & Christianson, 
2015).  It is essential that the provider quality information is meaningful and indicative of 
the care provided.  Studies, such as this one, are essential to analyze consumer available 
scores and grades to determine if correlations exist between the various ratings and 
patient care.  Healthcare providers, like healthcare consumers, must be aware of how 
their care is represented within each rating system.  Knowing how each rating system 
represents care allows healthcare providers and organizations to know which areas to 
focus their process improvement activities while benchmarking themselves against 
similar organizations.    
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Positive Social Change 
 The one facet of healthcare that can never be lost among the current wave of 
patient satisfaction initiatives is the importance of understanding that patient outcomes, 
specifically reduced mortality risks, are still the most critical aspect of care to healthcare 
consumers (Mühlbacher & Bethge, 2015).  Therefore, determining if there is an 
alignment between publicly available healthcare provider ratings and patient outcome 
data, allows healthcare consumers to make more informed decisions where to receive 
their care.  Studies, like this one, continue to demonstrate the strengths and weaknesses of 
the various rating systems and ensure they align with consumer expectations. While this 
study helped elucidate that Leapfrog grades are not reliable predictors of patient 
outcomes, it also demonstrated that efforts to reduce 30-day mortality rates, especially for 
pneumonia, can be targeted by selected states, ownership type, and teaching status. 
Conclusion 
 Leapfrog Hospital Safety Grades demonstrated a statistically significant 
correlation for pneumonia 30-day mortality rates.  However, Leapfrog grades are poorly 
correlated with patient 30-day mortality outcomes for CHF and AMI.  The study also 
demonstrated, except for ownership type, the independent variables could not be used as 
a reliable predictor of patient outcomes across all three dependent variables.  However, 
except for safety-net status, all the covariates did provide some predictive value of for at 
least one of the analyzed outcomes.  Organizational ownership type did provide 
predictive value for all three depended variables. However, in most cases, the effect (β) 
was small. 
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 The lack of a consistent correlation between Leapfrog grades and patient 
outcomes is a significant finding.  Since mortality risk is still the most critical factor for 
patients (Mühlbacher & Bethge, 2015), demonstrating how publicly available grades 
align, or fail to align, with outcomes is of importance to healthcare consumers.  This 
study demonstrates that there is a gap, at least between Leapfrog grades and the CHF and 
AMI outcomes, which need to be addressed to ensure that rating systems are consistently 
ranking per what is vital to consumers. 
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